Finance

Lists
MET-F:NYSE
Metlife 1000 DS Rep Prf Series F
USD 16,91
-0,29%
(-0,050) 1D
9 Okt., 16:00:08 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MET-F...
Open
USD 16,95
High
USD 16,95
Low
USD 16,79
Mkt. cap
62,49 mjd
Avg. vol.
162,34 k
Volume
135,61 k
52-wk high
USD 21,13
52-wk low
USD 16,61
Beta
0,62
Shares outstanding
40,00 m
No. of employees
46 k
Open
USD 16,95
High
USD 16,95
Low
USD 16,79
Mkt. cap
62,49 mjd
Avg. vol.
162,34 k
Volume
135,61 k
52-wk high
USD 21,13
52-wk low
USD 16,61
Beta
0,62
Shares outstanding
40,00 m
No. of employees
46 k
News stories
From web sources and news partners
Profile
MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company, better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. On January 6, 1915, MetLife completed the mutualization process, changing from a stock life insurance company owned by individuals to a mutual company operating without external shareholders and for the benefit of policyholders. After 85 years as a mutual company, MetLife demutualized into a publicly traded company with an initial public offering in 2000. Through its subsidiaries and affiliates, MetLife holds leading market positions in the United States, Japan, Latin America, Asia's Pacific region, Europe, and the Middle East. MetLife serves 90 of the largest Fortune 500 companies. Wikipedia
About Metlife 1000 DS Rep Prf Series F
CEOMichel A. Khalaf
Employees46 k
Founded24 Mrt. 1868
HeadquartersNew York Stad, New York, Verenigde State van Amerika
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
17,36 mjd
23,81 mjd
19,07 mjd
19,15 mjd
Cost of goods sold
12,90 mjd
19,28 mjd
13,65 mjd
14,54 mjd
Cost of revenue
12,90 mjd
19,28 mjd
13,65 mjd
14,54 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
3,24 mjd
3,42 mjd
3,53 mjd
3,55 mjd
Total operating expenses
16,14 mjd
22,70 mjd
17,18 mjd
18,10 mjd
Operating income
1,22 mjd
1,11 mjd
1,89 mjd
1,06 mjd
Other non operating income
263,00 m
267,00 m
-120,00 m
270,00 m
EBT including unusual items
1,21 mjd
1,12 mjd
1,51 mjd
1,04 mjd
EBT excluding unusual items
1,21 mjd
1,12 mjd
1,51 mjd
1,04 mjd
Income tax expense
308,00 m
301,00 m
345,00 m
256,00 m
Effective tax rate
25,45%
26,95%
22,89%
24,73%
Other operating expenses
3,24 mjd
3,42 mjd
3,53 mjd
3,55 mjd
Net income
896,00 m
809,00 m
1,18 mjd
736,00 m
Net profit margin
5,16%
3,40%
6,21%
3,84%
Earnings per share
2,37
2,49
2,42
2,43
Interest and investment income
-
-
-
-
Interest expense
-271,00 m
-263,00 m
-265,00 m
-292,00 m
Net interest expenses
-271,00 m
-263,00 m
-265,00 m
-292,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,25 mjd
1,78 mjd
1,92 mjd
1,10 mjd
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme